VRCA Nov 2024 2.500 call
| Previous close | 4.4500 |
| Open | 4.4500 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 2.50 |
| Expiry date | 2024-11-15 |
| Day's range | 4.4500 - 4.4500 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Simply Wall St.High Insider Ownership Growth Stocks On US Exchange For June 2024
As the U.S. stock market experiences fluctuations, with recent slips in major indices like the Dow Jones, S&P 500, and Nasdaq from record highs, investors are keenly observing market dynamics and economic indicators such as inflation rates and interest rate expectations. In this context, examining growth companies with high insider ownership might offer valuable insights, as these firms often demonstrate a strong alignment between management's interests and shareholder returns.
- Simply Wall St.
Recent 12% pullback would hurt Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) insiders
Key Insights Insiders appear to have a vested interest in Verrica Pharmaceuticals' growth, as seen by their sizeable...
GlobeNewswireVerrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
WEST CHESTER, Pa., May 30, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Ted White, President and Chief Executive Officer of Verrica Pharmaceuticals, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York City. Jefferies Global Healthcare Conference, New York, June 6, 2024.Even
